Nutex Health, Inc.·4

May 10, 4:00 PM ET

Bates Jon Christian 4

4 · Nutex Health, Inc. · Filed May 10, 2023

Insider Transaction Report

Form 4
Period: 2023-04-01
Bates Jon Christian
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-04-01+49,50549,505 total
  • Exercise/Conversion

    Common Stock

    2023-04-01+20,00069,505 total
  • Award

    Restricted Stock Unit

    2023-04-01+148,515148,515 total
    Common Stock (148,515 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2023-04-0149,50599,010 total
    Common Stock (49,505 underlying)
  • Award

    Restricted Stock Unit

    2023-04-01+20,00020,000 total
    Common Stock (20,000 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2023-04-0120,0000 total
    Common Stock (20,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
  • [F2]Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated April 1, 2023, the 148,515 RSUs granted to Mr. Bates will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.
  • [F3]Represents 20,000 RSUs issued and vested on April 1, 2023.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES